NCT06006715

Brief Summary

The objectives of this study are: Firstly, to investigate the association between psychiatric disorders and functional somatic disorder (FSD). Secondly, to investigate whether psychiatric disorders are risk factors for newly developed (incident) FSD after a 5-year follow-up period.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,493

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2011

Completed
9.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2021

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

August 17, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 23, 2023

Completed
Last Updated

September 8, 2023

Status Verified

August 1, 2023

Enrollment Period

9.2 years

First QC Date

August 17, 2023

Last Update Submit

September 5, 2023

Conditions

Outcome Measures

Primary Outcomes (10)

  • Questionnaire-defined Functional somatic disorder at baseline

    Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with self-reported questionnaires.

    At the DanFunD baseline investigation

  • Interview-based Functional somatic disorder at baseline

    Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with diagnostic interviews.

    Time Frame: At the DanFunD baseline investigation

  • Questionnaire-defined Functional somatic disorder at 5-year follow-up

    Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with self-reported questionnaires.

    Time Frame: At the DanFunD 5-year follow-up investigation

  • Interview-based Functional somatic disorder at 5-year follow-up

    Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with diagnostic interviews.

    Time Frame: At the DanFunD 5-year follow-up investigation

  • Irritable bowel at baseline

    Participants fulfilling the diagnostic criteria for irritable bowel will be identified with self-reported questionnaires

    Time Frame: At the DanFunD baseline investigation

  • Irritable bowel at 5-year follow-up

    Participants fulfilling the diagnostic criteria for irritable bowel will be identified with self-reported questionnaires

    Time Frame: At the DanFunD 5-year follow-up investigation

  • Chronic widespread pain at baseline

    Participants fulfilling the diagnostic criteria for chronic widespread pain will be identified with self-reported questionnaires

    Time Frame: At the DanFunD baseline investigation

  • Chronic widespread pain at 5-year follow-up

    Participants fulfilling the diagnostic criteria for chronic widespread pain will be identified with self-reported questionnaires.

    Time Frame: At the DanFunD 5-year follow-up investigation

  • Chronic fatigue at baseline

    Participants fulfilling the diagnostic criteria for chronic fatigue will be identified with self-reported questionnaires.

    Time Frame: At the DanFunD baseline investigation

  • Chronic fatigue at 5-year follow-up

    Participants fulfilling the diagnostic criteria for chronic fatigue will be identified with self-reported questionnaires.

    Time Frame: At the DanFunD 5-year follow-up investigation

Other Outcomes (6)

  • Presence of psychiatric disorders (overall): Yes/no

    Time frame: Given within 10 years before the DanFunD baseline investigation.

  • Presence of anxiety disorders: Yes/no

    Time frame: Given within 10 years before the DanFunD baseline investigation.

  • Presence of depression: Yes/no

    Time frame: Given within 10 years before the DanFunD baseline investigation.

  • +3 more other outcomes

Study Arms (2)

DanFunD baseline

The baseline cohort (gathered in the years 2012-2015) is a random sample selected through the National Civil Registration system among people living in 10 municipalities in the western part of greater Copenhagen, Denmark, ages 18 to 76 years. The baseline cohort constitutes data from self-reported questionnaires (n=7,493) and diagnostic interviews data (n=1,590).

DanFunD 5-years follow-up investigation

The follow-up cohort (gathered in the years 2018-2020) consists of participants all born in Denmark, between 24 and 84 years of age. The follow-up cohort constitutes data from self-reported questionnaires (n=4,288) and diagnostic interviews data (n=1,094).

Eligibility Criteria

Age18 Years - 84 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A total of 25,368 participants were randomly drawn from the adult general Danish population by means of the the Danish Civil Registration system. The DanFunD baseline cohort comprises a total of 7,493 (29.5% of invited participants) men and women aged 18-76 years, born in Denmark, and living in the Western part of greater Copenhagen. The follow-up cohort (gathered in the years 2018-2020) consists of participants all born in Denmark, between 24 and 84 years of age. The follow-up cohort constitutes data from self-reported questionnaires (n=4,288) and diagnostic interviews data (n=1,094).

You may qualify if:

  • None

You may not qualify if:

  • Not born in Denmark
  • Not being a Danish citizen
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Irritable Bowel SyndromeFibromyalgiaFatigue Syndrome, ChronicSomatoform Disorders

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMuscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesEncephalomyelitisNeuroinflammatory DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Per Fink, DMSc

    Aarhus University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2023

First Posted

August 23, 2023

Study Start

November 10, 2011

Primary Completion

January 4, 2021

Study Completion

August 30, 2022

Last Updated

September 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Restrictions apply to the availability of data according to Danish law, which means that data cannot be made publicly available. A request for collaboration or access to data can be sent to ckff@regionh.dk. An application for data should consist of a short synopsis of the study planned. Please see our website (www. danfund.org) for more information.